Company
Headquarters: Virginia Beach, VA, United States
Employees: 1
CEO: Dr. Rhonda Keaveney J.D.
$32
USD as of May 1, 2022
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
NuOncology Labs, Inc. does not have significant operations. Previously, it was operated as commercial laboratory and provided predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. The company was incorporated in 1994 and is based in Scottsdale, Arizona.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
NuOncology Labs, Inc. has the following listings and related stock indices.
Stock: OTC: NLAB wb_incandescent
Headquarters:
4870 Haygood Road
Suite 107
Virginia Beach, VA 23455
United States
Phone: 757-554-0926